 |
Previous Article | Next Article 
Volume 17, Number 18,
Issue of September 15, 1997
pp. 7053-7059
Copyright ©1997 Society for Neuroscience
A Deposition Is Associated with Neuropil Changes, but not with
Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F
(PDAPP) Transgenic Mouse
Received April 4, 1997; revised June 4, 1997; accepted July 1, 1997.
Michael C. Irizarry1,
Ferdie Soriano2,
Megan McNamara1,
Keith J. Page1,
Dale Schenk2,
Dora Games2, and
Bradley T. Hyman1
1 Department of Neurology, Massachusetts General
Hospital, Boston, Massachusetts, 02114 and 2 Athena
Neurosciences, South San Francisco, California 94080
The PDAPP transgenic mouse overexpresses human amyloid precursor
protein V717F (PDAPP minigene) and develops age-related cerebral amyloid- protein (A ) deposits similar to senile plaques in
Alzheimer's disease. We find age-related cortical and limbic A
deposition that begins at 8 months and progresses to cover 20-50% of
the neuropil in cingulate cortex, entorhinal cortex, and hippocampus of
18-month-old heterozygotic animals. The regional patterns of transgene
expression and amyloid deposition suggest that A deposits occur at
the terminals of overexpressing neurons. Amyloid deposition is
associated with dystrophic neurites and extensive gliosis. However,
stereological analysis shows that there is no overt neuronal loss in
entorhinal cortex, CA1 hippocampal subfield, or cingulate cortex
through 18 months of age. In addition, there is no apparent loss of
mRNA encoding neuronal synaptic, cytoskeletal, or metabolic proteins.
Thus, widespread A deposition in 18-month-old heterozygotic mice
produces neuritic alterations and gliosis without widespread neuronal
death.
Key words:
transgenic mice;
Alzheimer's disease;
hippocampus;
amyloid;
amyloid precursor protein;
cingulate cortex;
entorhinal
cortex;
neuritic dystrophy;
synaptophysin;
microtubule associated
protein-2;
cytochrome oxidase;
glial fibrillary acidic protein
This article has been cited by other articles:

|
 |

|
 |
 
M. Hayashi, H. Arima, N. Ozaki, Y. Morishita, M. Hiroi, N. Ozaki, H. Nagasaki, N. Kinoshita, M. Ueda, A. Shiota, et al.
Progressive polyuria without vasopressin neuron loss in a mouse model for familial neurohypophysial diabetes insipidus
Am J Physiol Regulatory Integrative Comp Physiol,
May 1, 2009;
296(5):
R1641 - R1649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Yankner and T. Lu
Amyloid {beta}-Protein Toxicity and the Pathogenesis of Alzheimer Disease
J. Biol. Chem.,
February 20, 2009;
284(8):
4755 - 4759.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liu, M.-J. Yoo, A. Savonenko, W. Stirling, D. L. Price, D. R. Borchelt, L. Mamounas, W. E. Lyons, M. E. Blue, and M. K. Lee
Amyloid Pathology Is Associated with Progressive Monoaminergic Neurodegeneration in a Transgenic Mouse Model of Alzheimer's Disease
J. Neurosci.,
December 17, 2008;
28(51):
13805 - 13814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Daumas, J. Sandin, K. S. Chen, D. Kobayashi, J. Tulloch, S. J. Martin, D. Games, and R. G.M. Morris
Faster forgetting contributes to impaired spatial memory in the PDAPP mouse: Deficit in memory retrieval associated with increased sensitivity to interference?
Learn. Mem.,
August 26, 2008;
15(9):
625 - 632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maier, Y. Peng, L. Jiang, T. J. Seabrook, M. C. Carroll, and C. A. Lemere
Complement C3 Deficiency Leads to Accelerated Amyloid {beta} Plaque Deposition and Neurodegeneration and Modulation of the Microglia/Macrophage Phenotype in Amyloid Precursor Protein Transgenic Mice
J. Neurosci.,
June 18, 2008;
28(25):
6333 - 6341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sturchler, A. Galichet, M. Weibel, E. Leclerc, and C. W. Heizmann
Site-Specific Blockade of RAGE-Vd Prevents Amyloid-{beta} Oligomer Neurotoxicity
J. Neurosci.,
May 14, 2008;
28(20):
5149 - 5158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Kotilinek, M. A. Westerman, Q. Wang, K. Panizzon, G. P. Lim, A. Simonyi, S. Lesne, A. Falinska, L. H. Younkin, S. G. Younkin, et al.
Cyclooxygenase-2 inhibition improves amyloid-{beta}-mediated suppression of memory and synaptic plasticity
Brain,
March 1, 2008;
131(3):
651 - 664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-g. Lee, X. Zhu, R. J. Castellani, A. Nunomura, G. Perry, and M. A. Smith
Amyloid-beta in Alzheimer Disease: The Null versus the Alternate Hypotheses
J. Pharmacol. Exp. Ther.,
June 1, 2007;
321(3):
823 - 829.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhu, J. Avila, G. Perry, and M. A. Smith
Treating the Lesions, Not the Disease
Am. J. Pathol.,
May 1, 2007;
170(5):
1457 - 1459.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Garzon and M. Fahnestock
Oligomeric Amyloid Decreases Basal Levels of Brain-Derived Neurotrophic factor (BDNF) mRNA via Specific Downregulation of BDNF Transcripts IV and V in Differentiated Human Neuroblastoma Cells
J. Neurosci.,
March 7, 2007;
27(10):
2628 - 2635.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Thomas and M. Fenech
A review of genome mutation and Alzheimer's disease
Mutagenesis,
January 1, 2007;
22(1):
15 - 33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Galvan, O. F. Gorostiza, S. Banwait, M. Ataie, A. V. Logvinova, S. Sitaraman, E. Carlson, S. A. Sagi, N. Chevallier, K. Jin, et al.
Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664
PNAS,
May 2, 2006;
103(18):
7130 - 7135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Thal, E. Capetillo-Zarate, K. Del Tredici, and H. Braak
The Development of Amyloid beta Protein Deposits in the Aged Brain
Sci. Aging Knowl. Environ.,
March 8, 2006;
2006(6):
re1 - re1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Rossi, L. Brambilla, C. F. Valori, A. Crugnola, G. Giaccone, R. Capobianco, M. Mangieri, A. E. Kingston, A. Bloc, P. Bezzi, et al.
Defective Tumor Necrosis Factor-{alpha}-dependent Control of Astrocyte Glutamate Release in a Transgenic Mouse Model of Alzheimer Disease
J. Biol. Chem.,
December 23, 2005;
280(51):
42088 - 42096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ramsden, L. Kotilinek, C. Forster, J. Paulson, E. McGowan, K. SantaCruz, A. Guimaraes, M. Yue, J. Lewis, G. Carlson, et al.
Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L)
J. Neurosci.,
November 16, 2005;
25(46):
10637 - 10647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Spires, M. Meyer-Luehmann, E. A. Stern, P. J. McLean, J. Skoch, P. T. Nguyen, B. J. Bacskai, and B. T. Hyman
Dendritic Spine Abnormalities in Amyloid Precursor Protein Transgenic Mice Demonstrated by Gene Transfer and Intravital Multiphoton Microscopy
J. Neurosci.,
August 3, 2005;
25(31):
7278 - 7287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Herrup, R. Neve, S. L. Ackerman, and A. Copani
Divide and Die: Cell Cycle Events as Triggers of Nerve Cell Death
J. Neurosci.,
October 20, 2004;
24(42):
9232 - 9239.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Stein, N. J. Anders, C. DeCarli, S. L. Chan, M. P. Mattson, and J. A. Johnson
Neutralization of Transthyretin Reverses the Neuroprotective Effects of Secreted Amyloid Precursor Protein (APP) in APPSw Mice Resulting in Tau Phosphorylation and Loss of Hippocampal Neurons: Support for the Amyloid Hypothesis
J. Neurosci.,
September 1, 2004;
24(35):
7707 - 7717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. I. Fonseca, J. Zhou, M. Botto, and A. J. Tenner
Absence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease
J. Neurosci.,
July 21, 2004;
24(29):
6457 - 6465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-C. Wu, F. Chawla, D. Games, R. E. Rydel, S. Freedman, D. Schenk, W. G. Young, J. H. Morrison, and F. E. Bloom
Selective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: Digital morphometric analyses
PNAS,
May 4, 2004;
101(18):
7141 - 7146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Dickson
Building a More Perfect Beast: APP Transgenic Mice with Neuronal Loss
Am. J. Pathol.,
April 1, 2004;
164(4):
1143 - 1146.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schmitz, B. P. F. Rutten, A. Pielen, S. Schafer, O. Wirths, G. Tremp, C. Czech, V. Blanchard, G. Multhaup, P. Rezaie, et al.
Hippocampal Neuron Loss Exceeds Amyloid Plaque Load in a Transgenic Mouse Model of Alzheimer's Disease
Am. J. Pathol.,
April 1, 2004;
164(4):
1495 - 1502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Fukumoto, D. L. Rosene, M. B. Moss, S. Raju, B. T. Hyman, and M. C. Irizarry
{beta}-Secretase Activity Increases with Aging in Human, Monkey, and Mouse Brain
Am. J. Pathol.,
February 1, 2004;
164(2):
719 - 725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Lombardo, E. A. Stern, M. E. McLellan, S. T. Kajdasz, G. A. Hickey, B. J. Bacskai, and B. T. Hyman
Amyloid-{beta} Antibody Treatment Leads to Rapid Normalization of Plaque-Induced Neuritic Alterations
J. Neurosci.,
November 26, 2003;
23(34):
10879 - 10883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Abe, K. Kouyama, T. Tomita, Y. Tomita, N. Ban, M. Nawa, M. Matsuoka, T. Niikura, S. Aiso, Y. Kita, et al.
Analysis of Neurons Created from Wild-Type and Alzheimer's Mutation Knock-In Embryonic Stem Cells by a Highly Efficient Differentiation Protocol
J. Neurosci.,
September 17, 2003;
23(24):
8513 - 8525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Zhong, Z. Gu, X. Wang, H. Jiang, J. Feng, and Z. Yan
Impaired Modulation of GABAergic Transmission by Muscarinic Receptors in a Mouse Transgenic Model of Alzheimer's Disease
J. Biol. Chem.,
July 11, 2003;
278(29):
26888 - 26896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Gu, P. Zhong, and Z. Yan
Activation of Muscarinic Receptors Inhibits beta -Amyloid Peptide-induced Signaling in Cortical Slices
J. Biol. Chem.,
May 2, 2003;
278(19):
17546 - 17556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Reilly, D. Games, R. E. Rydel, S. Freedman, D. Schenk, W. G. Young, J. H. Morrison, and F. E. Bloom
Amyloid deposition in the hippocampus and entorhinal cortex: Quantitative analysis of a transgenic mouse model
PNAS,
April 15, 2003;
100(8):
4837 - 4842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. B. Stine Jr., K. N. Dahlgren, G. A. Krafft, and M. J. LaDu
In Vitro Characterization of Conditions for Amyloid-beta Peptide Oligomerization and Fibrillogenesis
J. Biol. Chem.,
March 21, 2003;
278(13):
11612 - 11622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Uchida
Overexpression of Full-length but Not N-terminal Truncated Isoform of Microtubule-associated Protein (MAP) 1B Accelerates Apoptosis of Cultured Cortical Neurons
J. Biol. Chem.,
January 3, 2003;
278(1):
366 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. N. Prasad, W. C. Cole, and K. C. Prasad
Risk Factors for Alzheimer's Disease: Role of Multiple Antioxidants, Non-Steroidal Anti-inflammatory and Cholinergic Agents Alone or in Combination in Prevention and Treatment
J. Am. Coll. Nutr.,
December 1, 2002;
21(6):
506 - 522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Lazarov, M. Lee, D. A. Peterson, and S. S. Sisodia
Evidence That Synaptically Released beta -Amyloid Accumulates as Extracellular Deposits in the Hippocampus of Transgenic Mice
J. Neurosci.,
November 15, 2002;
22(22):
9785 - 9793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Urbanc, L. Cruz, R. Le, J. Sanders, K. H. Ashe, K. Duff, H. E. Stanley, M. C. Irizarry, and B. T. Hyman
Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease
PNAS,
October 29, 2002;
99(22):
13990 - 13995.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Stein and J. A. Johnson
Lack of Neurodegeneration in Transgenic Mice Overexpressing Mutant Amyloid Precursor Protein Is Associated with Increased Levels of Transthyretin and the Activation of Cell Survival Pathways
J. Neurosci.,
September 1, 2002;
22(17):
7380 - 7388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Suh and F. Checler
Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease
Pharmacol. Rev.,
September 1, 2002;
54(3):
469 - 525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Thal, U. Rub, M. Orantes, and H. Braak
Phases of A{beta}-deposition in the human brain and its relevance for the development of AD
Neurology,
June 25, 2002;
58(12):
1791 - 1800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bondolfi, M. Calhoun, F. Ermini, H. G. Kuhn, K.-H. Wiederhold, L. Walker, M. Staufenbiel, and M. Jucker
Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic Mice
J. Neurosci.,
January 15, 2002;
22(2):
515 - 522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Koistinaho, M. Ort, J. M. Cimadevilla, R. Vondrous, B. Cordell, J. Koistinaho, J. Bures, and L. S. Higgins
Specific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta -amyloid deposits but do not form plaques
PNAS,
November 20, 2001;
(2001)
261562998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Deng, M. C. Irizarry, R. M. Nitsch, J. H. Growdon, and G. W. Rebeck
Elevation of Cystatin C in Susceptible Neurons in Alzheimer's Disease
Am. J. Pathol.,
September 1, 2001;
159(3):
1061 - 1068.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Dineley, M. Westerman, D. Bui, K. Bell, K. H. Ashe, and J. D. Sweatt
{beta}-Amyloid Activates the Mitogen-Activated Protein Kinase Cascade via Hippocampal {alpha}7 Nicotinic Acetylcholine Receptors: In Vitro and In Vivo Mechanisms Related to Alzheimer's Disease
J. Neurosci.,
June 15, 2001;
21(12):
4125 - 4133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Irizarry, J. J. Locascio, and B. T. Hyman
{beta}-Site APP Cleaving Enzyme mRNA Expression in APP Transgenic Mice : Anatomical Overlap with Transgene Expression and Static Levels with Aging
Am. J. Pathol.,
January 1, 2001;
158(1):
173 - 177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Takeuchi, M. C. Irizarry, K. Duff, T. C. Saido, K. Hsiao Ashe, M. Hasegawa, D. M. A. Mann, B. T. Hyman, and T. Iwatsubo
Age-Related Amyloid {beta} Deposition in Transgenic Mice Overexpressing Both Alzheimer Mutant Presenilin 1 and Amyloid {beta} Precursor Protein Swedish Mutant Is Not Associated with Global Neuronal Loss
Am. J. Pathol.,
July 1, 2000;
157(1):
331 - 339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Skovronsky, B. Zhang, M.-P. Kung, H. F. Kung, J. Q. Trojanowski, and V. M.-Y. Lee
In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease
PNAS,
June 20, 2000;
97(13):
7609 - 7614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Nau, L. Liaw, G. L. Chupp, J. S. Berman, B. L. M. Hogan, and R. A. Young
Attenuated Host Resistance against Mycobacterium bovis BCG Infection in Mice Lacking Osteopontin
Infect. Immun.,
August 1, 1999;
67(8):
4223 - 4230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Funato, M. Enya, M. Yoshimura, M. Morishima-Kawashima, and Y. Ihara
Presence of Sodium Dodecyl Sulfate-Stable Amyloid {beta}-Protein Dimers in the Hippocampus CA1 Not Exhibiting Neurofibrillary Tangle Formation
Am. J. Pathol.,
July 1, 1999;
155(1):
23 - 28.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stalder, A. Phinney, A. Probst, B. Sommer, M. Staufenbiel, and M. Jucker
Association of Microglia with Amyloid Plaques in Brains of APP23 Transgenic Mice
Am. J. Pathol.,
June 1, 1999;
154(6):
1673 - 1684.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Knowles, C. Wyart, S. V. Buldyrev, L. Cruz, B. Urbanc, M. E. Hasselmo, H. E. Stanley, and B. T. Hyman
Plaque-induced neurite abnormalities: Implications for disruption of neural networks in Alzheimer's disease
PNAS,
April 27, 1999;
96(9):
5274 - 5279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Y. Hsia, E. Masliah, L. McConlogue, G.-Q. Yu, G. Tatsuno, K. Hu, D. Kholodenko, R. C. Malenka, R. A. Nicoll, and L. Mucke
Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
PNAS,
March 16, 1999;
96(6):
3228 - 3233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Moechars, I. Dewachter, K. Lorent, D. Reverse, V. Baekelandt, A. Naidu, I. Tesseur, K. Spittaels, C. V. D. Haute, F. Checler, et al.
Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain
J. Biol. Chem.,
March 5, 1999;
274(10):
6483 - 6492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Goedert and M. Hasegawa
The Tauopathies : Toward an Experimental Animal Model
Am. J. Pathol.,
January 1, 1999;
154(1):
1 - 6.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Enya, M. Morishima-Kawashima, M. Yoshimura, Y. Shinkai, K. Kusui, K. Khan, D. Games, D. Schenk, S. Sugihara, H. Yamaguchi, et al.
Appearance of Sodium Dodecyl Sulfate-Stable Amyloid ß-Protein (Aß) Dimer in the Cortex During Aging
Am. J. Pathol.,
January 1, 1999;
154(1):
271 - 279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. PICCIOTTO and K. WICKMAN
Using Knockout and Transgenic Mice to Study Neurophysiology and Behavior
Physiol Rev,
October 1, 1998;
78(4):
1131 - 1163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Smith, M. Nakamura, T. K. McIntosh, J. Wang, A. Rodriguez, X.-H. Chen, R. Raghupathi, K. E. Saatman, J. Clemens, M. L. Schmidt, et al.
Brain Trauma Induces Massive Hippocampal Neuron Death Linked to a Surge in ß-Amyloid Levels in Mice Overexpressing Mutant Amyloid Precursor Protein
Am. J. Pathol.,
September 1, 1998;
153(3):
1005 - 1010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Nishimura, T. Uetsuki, S. U. Dani, Y. Ohsawa, I. Saito, H. Okamura, Y. Uchiyama, and K. Yoshikawa
Degeneration In Vivo of Rat Hippocampal Neurons by Wild-Type Alzheimer Amyloid Precursor Protein Overexpressed by Adenovirus-Mediated Gene Transfer
J. Neurosci.,
April 1, 1998;
18(7):
2387 - 2398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Morrison and P. R. Hof
Life and Death of Neurons in the Aging Brain
Science,
October 17, 1997;
278(5337):
412 - 419.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Yoshiike, K. Tanemura, O. Murayama, T. Akagi, M. Murayama, S. Sato, X. Sun, N. Tanaka, and A. Takashima
New Insights on How Metals Disrupt Amyloid beta -Aggregation and Their Effects on Amyloid-beta Cytotoxicity
J. Biol. Chem.,
August 17, 2001;
276(34):
32293 - 32299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Chishti, D.-S. Yang, C. Janus, A. L. Phinney, P. Horne, J. Pearson, R. Strome, N. Zuker, J. Loukides, J. French, et al.
Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695
J. Biol. Chem.,
June 8, 2001;
276(24):
21562 - 21570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Buldyrev, L. Cruz, T. Gomez-Isla, E. Gomez-Tortosa, S. Havlin, R. Le, H. E. Stanley, B. Urbanc, and B. T. Hyman
From the Cover: Description of microcolumnar ensembles in association cortex and their disruption in Alzheimer and Lewy body dementias
PNAS,
May 9, 2000;
97(10):
5039 - 5043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Koistinaho, M. Ort, J. M. Cimadevilla, R. Vondrous, B. Cordell, J. Koistinaho, J. Bures, and L. S. Higgins
Specific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta -amyloid deposits but do not form plaques
PNAS,
December 4, 2001;
98(25):
14675 - 14680.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|